Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC46H68N4O11 |
InChIKeyRZIQIEBBFSSCIQ-KMRDRQGYSA-N |
CAS Registry1225383-41-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NL | 25 Jan 2019 |